Bringing key actors in global public health to New York City to reflect on progress and shortcomings, consider the evidence and report on analyses of recent data, and chart out ways to effectively tackle current challenges by drawing on lessons from the past decade.
In October 2009, MSF and the Drugs for Neglected Diseases initiative (DNDi) hosted a symposium at UCLA in Los Angeles to raise awareness about Chagas disease in the US and Latin America, discuss the challenges of increasing diagnosis, treatment, and R&D, and produce calls for action.
University of California, Los Angeles (UCLA) Faculty Center
In September 2008, Doctors Without Borders/ Médecins Sans Frontières and Columbia University's Institute of Human Nutrition will convene a meeting of lead national and international organizations and experts to review recent successes and examine how international nutrition and food aid programming can more effectively address the crisis of malnutrition in high burden regions. At a time of rising food prices and food insecurity, the need to scale up efforts to prevent the deaths, illness and disability caused by malnutrition every year is even more urgent.
On August 3, 2008, Doctors Without Borders/Médecins Sans Frontières (MSF) invites you to attend a Satellite meeting on the impact of the health care worker shortage on access to HIV/AIDS treatment and lessons learned from clinicians and advocates working on the ground to overcome this gap. Mexico City 2008.
This symposium aims to discuss how to improve current practices with the tools that exist today and to explore the implementation of emerging technologies and applications. Participants will also be invited to analyse the roadblocks holding up the development and implementation of improved TB/MDR-TB testing and contribute to developing strategies for challenging stakeholders to overcome these obstacles and put an end to the global neglect of these issues.
On January 11, 2007, Doctors Without Borders/Médecins Sans Frontières, supported by Weill Cornell Medical College, convened a symposium entitled "No Time to Wait" in New York aimed at stimulating efforts to accelerate the development of effective new treatments for tuberculosis (TB).
The World Health Organization has recommended artemisinin-based combination therapy (ACT) to replace the failing drugs in order to reduce mortality and delay further development of resistance. Yet, progress has been slow in getting these new medicines to patients.